FALLON LYNNETTE C 4
4 · ClearPoint Neuro, Inc. · Filed May 15, 2024
Insider Transaction Report
Form 4
FALLON LYNNETTE C
Director
Transactions
- Exercise/Conversion
Common Stock
2024-05-14+17,153→ 30,008 total - Exercise/Conversion
Restricted Stock Units
2024-05-14−17,153→ 0 total→ Common Stock (17,153 underlying)
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On May 25, 2023, the reporting person was granted 17,153 restricted stock units, vesting on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2024 annual meeting of stockholders.